First-line treatment of inoperable pancreatic adenocarcinoma with lipid complexed paclitaxel nanoparticles plus gemcitabine compared with gemcitabine monotherapy. A prospective RCT - phase II study
2008 ◽
Vol 26
(15_suppl)
◽
pp. 4618-4618
◽
Keyword(s):
Phase Ii
◽